Free Trial

Fortrea Q3 2024 Earnings Report

Fortrea logo
$23.10 +1.52 (+7.04%)
(As of 01:51 PM ET)

Fortrea EPS Results

Actual EPS
$0.23
Consensus EPS
$0.25
Beat/Miss
Missed by -$0.02
One Year Ago EPS
$0.24

Fortrea Revenue Results

Actual Revenue
$674.90 million
Expected Revenue
$674.86 million
Beat/Miss
Beat by +$40.00 thousand
YoY Revenue Growth
-5.40%

Fortrea Announcement Details

Quarter
Q3 2024
Time
Before Market Opens
Coins Set to Soar with a Pro-Crypto White House (Ad)

Coins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over $3 Million worth of crypto – and he's not the only one at the top interested in digital assets…

Click here to reserve your free seat at the Crypto Community Summit

Fortrea Earnings Headlines

Fortrea: Some Green Shoots After A Dismal Period
Brokerages Set Fortrea Holdings Inc. (NASDAQ:FTRE) PT at $24.50
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.
Fortrea to Present at the Evercore HealthCONx Conference
See More Fortrea Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Fortrea? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Fortrea and other key companies, straight to your email.

About Fortrea

Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.

View Fortrea Profile

More Earnings Resources from MarketBeat